New legislation shortens MU reporting period to 90 days

New legislation would reduce the Meaningful Use reporting period this year from a full year to 90 days.

Healthcare organizations have been pushing for the switch sending letters to legislators and leaders of the Department of Health and Human Services. Sens. Rob Portman (R-Ohio) and Michael Bennet (D-Colo.) and Reps. Renee Ellmers (R-Mich.), Tom Price (R-Ga.), Bobby Rush (D-Ill.) and Ron Kind (D-Wisc.) introduced bipartisan legislation, the Flexibility in EHR Reporting Act.

"The continued procrastination by CMS to provide relief from the tough and inflexible deadlines within the Meaningful Use program has prompted myself and Senator Portman to rally our colleagues and take action," Ellmers said. "As a nurse, I continue to recognize the problems physicians, hospitals and healthcare providers face when working to meet CMS' stringent Meaningful Use requirements. While provider participation in this program is important, it's clear that our medical community is eager for relief but that CMS is in no hurry to provide it. Today's bipartisan and bicameral legislation is critical to the ongoing conversation about how to best serve patients and supply relief to the provider community."

Current regulations require providers to show data from a full year as part of MU attestation. Last year, the Centers for Medicare & Medicaid Services eased the requirements so that providers only had to submit data for a 90-day period for 2015.

 

 

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.